Trial Profile
A Randomized, Blind, active-controlled trials to evaluate the safety and immunogenicity of Quadrivalent influenza vaccine (Split Virion) for Human use in the healthy subjects among 6-months to 3 years old
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 29 Apr 2016 New trial record